There is at least a vaccine against one major cause of bacterial lung infections, pneumococcus, recommended for those at risk of flu complications by many health agencies.
Objective To compare the biochemical and immunological characteristics of pneumococcus type 1 conjugate vaccine prepared by cyanogen bromide activation and amine reduction.